Skip to content
lifestyle.gamezon.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Cantargia
Cantargia Publishes Half-Year Report 2026
August 19, 2026
Cantargia to Host Q2 2026 Interim Results Conference Call
August 4, 2026
Cantargia Announces Changes in Number of Shares and Votes
July 31, 2026
Cantargia Announces Publication of Data Supporting IL1RAP as a Therapeutic Target and Predictive Biomarker in PDAC
June 26, 2026
Cantargia and H.C. Wainwright to Host KOL Call on The Case for Nadunolimab in PDAC
June 11, 2026
Cantargia Announces Start of New Investigator-Initiated Lung Cancer Prevention Study
June 10, 2026
Invitation to the Presentation of Cantargia’s Interim Report for Q1 2026
May 6, 2026
Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML
April 27, 2026
Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC
April 17, 2026
Cantargia Publishes Annual Report 2025
April 17, 2026
1
2
Next Page
→